{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T18:53:57Z","timestamp":1776884037675,"version":"3.51.2"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,4,28]],"date-time":"2015-04-28T00:00:00Z","timestamp":1430179200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1038\/nrneph.2015.54","type":"journal-article","created":{"date-parts":[[2015,4,28]],"date-time":"2015-04-28T11:46:01Z","timestamp":1430221561000},"page":"371-384","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Primary disease recurrence\u2014effects on paediatric renal transplantation outcomes"],"prefix":"10.1038","volume":"11","author":[{"given":"Justine","family":"Bacchetta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Cochat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,28]]},"reference":[{"key":"BFnrneph201554_CR1","unstructured":"North American Pediatric Renal Trials and Collaborative Studies. NAPRTCS 2010 Annual Transplant Report. The EMMES Corporation\u2122 [online] , (2010)."},{"key":"BFnrneph201554_CR2","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1007\/s00467-009-1137-6","volume":"24","author":"P Cochat","year":"2009","unstructured":"Cochat, P. et al. Disease recurrence in paediatric renal transplantation. Pediatr. Nephrol. 24, 2097\u20132108 (2009).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201554_CR3","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1093\/ndt\/gfs549","volume":"28","author":"KJ Van Stralen","year":"2013","unstructured":"Van Stralen, K. J. et al. Impact of graft loss among kidney diseases with a high risk of post-transplant recurrence in the paediatric population. Nephrol. Dial. Transplant. 28, 1031\u20131038 (2013).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201554_CR4","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1007\/s00467-014-2781-z","volume":"29","author":"C Holmberg","year":"2014","unstructured":"Holmberg, C. & Jalanko, H. Congenital nephrotic syndrome and recurrence of proteinuria after renal transplantation. Pediatr. Nephrol. 29, 2309\u20132317 (2014).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201554_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1681\/ASN.2013050564","volume":"25","author":"G Canaud","year":"2014","unstructured":"Canaud, G. et al. The kidney as a reservoir for HIV1 after renal transplantation. J. Am. Soc. Nephrol. 25, 407\u2013419 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201554_CR6","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s00467-009-1138-5","volume":"24","author":"D Mekahli","year":"2009","unstructured":"Mekahli, D. et al. Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter study. Pediatr. Nephrol. 24, 1525\u20131532 (2009).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201554_CR7","volume-title":"Soci\u00e9t\u00e9 de n\u00e9phrologie","author":"J Harambat","year":"2013","unstructured":"Harambat, J. et al. Paediatric ESRD: 2013 data from the REIN registry. Soci\u00e9t\u00e9 de n\u00e9phrologie [online] , (2013)."},{"key":"BFnrneph201554_CR8","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s00467-006-0361-6","volume":"22","author":"RN Fine","year":"2007","unstructured":"Fine, R. N. Recurrence of nephrotic syndrome\/focal segmental glomerulosclerosis following renal transplantation in children. Pediatr. Nephrol. 22, 496\u2013502 (2007).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201554_CR9","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1034\/j.1399-3046.2002.02036.x","volume":"6","author":"MA Baum","year":"2002","unstructured":"Baum, M. A., Ho, M., Stablein, D. & Alexander, S. R. Outcome of renal transplantation in adolescents with focal segmental glomerulosclerosis. Pediatr. Transplant. 6, 488\u2013492 (2002).","journal-title":"Pediatr. Transplant."},{"key":"BFnrneph201554_CR10","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1007\/s00467-012-2218-5","volume":"27","author":"MA Saleem","year":"2012","unstructured":"Saleem, M. A. The phenomenon of focal segmental glomerulosclerosis posttransplantationa one-hit wonder? Pediatr. Nephrol. 27, 2163\u20132166 (2012).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201554_CR11","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/nm.2443","volume":"17","author":"SJ Shankland","year":"2011","unstructured":"Shankland, S. J. & Pollak, M. R. A suPAR circulating factor causes kidney disease. Nat. Med. 17, 926\u2013927 (2011).","journal-title":"Nat. Med."},{"key":"BFnrneph201554_CR12","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/nm.2411","volume":"17","author":"C Wei","year":"2011","unstructured":"Wei, C. et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat. Med. 17, 952\u2013960 (2011).","journal-title":"Nat. Med."},{"key":"BFnrneph201554_CR13","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1056\/NEJMc1202500","volume":"366","author":"L Gallon","year":"2012","unstructured":"Gallon, L., Leventhal, J., Skaro, A., Kanwar, Y. & Alvarado, A. Resolution of recurrent focal segmental glomerulosclerosis after retransplantation. N. Engl. J. Med. 366, 1648\u20131649 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201554_CR14","doi-asserted-by":"publisher","first-page":"436","DOI":"10.12659\/AOT.884003","volume":"18","author":"H Mohey","year":"2013","unstructured":"Mohey, H., Thibaudin, L., Laurent, B. & Berthoux, F. The podocin mutation R229Q and early recurrence (within the first year) of glomerular disease after renal transplantation. Ann. Transplant. 18, 436\u2013442 (2013).","journal-title":"Ann. Transplant."},{"key":"BFnrneph201554_CR15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/humu.22485","volume":"35","author":"K Bouchireb","year":"2014","unstructured":"Bouchireb, K. et al. NPHS2 mutations in steroid-resistant nephrotic syndrome: a mutation update and the associated phenotypic spectrum. Hum. Mutat. 35, 178\u2013186 (2014).","journal-title":"Hum. Mutat."},{"key":"BFnrneph201554_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5414\/CN107320","volume":"78","author":"AK Buscher","year":"2012","unstructured":"Buscher, A. K. et al. Mutations in podocyte genes are a rare cause of primary FSGS associated with ESRD in adult patients. Clin. Nephrol. 78, 47\u201353 (2012).","journal-title":"Clin. Nephrol."},{"key":"BFnrneph201554_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00467-001-0759-0","volume":"17","author":"M Fujisawa","year":"2002","unstructured":"Fujisawa, M. et al. Long term outcome of FSGS after Japanese pediatric renal transplantation. Pediatr. Nephrol. 17, 165\u2013168 (2002).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201554_CR18","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/j.1399-3046.2006.00571.x","volume":"10","author":"K Couloures","year":"2006","unstructured":"Couloures, K., Pepkowitz, S. H., Goldfinger, D., Kamil, E. S. & Puliyanda, D. P. Preventing recurrence of focal segmental glomerulosclerosis following renal transplantation: a case report. Pediatr. Transplant. 10, 962\u2013965 (2006).","journal-title":"Pediatr. Transplant."},{"key":"BFnrneph201554_CR19","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/j.1399-3046.2011.01478.x","volume":"15","author":"E Gonzalez","year":"2011","unstructured":"Gonzalez, E., Ettenger, R., Rianthavorn, P., Tsai, E. & Malekzadeh, M. Preemptive plasmapheresis and recurrence of focal segmental glomerulosclerosis in pediatric renal transplantation. Pediatr. Transplant. 15, 495\u2013501 (2011).","journal-title":"Pediatr. Transplant."},{"key":"BFnrneph201554_CR20","doi-asserted-by":"publisher","first-page":"E286","DOI":"10.1111\/j.1399-3046.2011.01610.x","volume":"16","author":"H Chikamoto","year":"2012","unstructured":"Chikamoto, H. et al. Pretransplantation combined therapy with plasmapheresis and rituximab in a second living-related kidney transplant pediatric recipient with a very high risk for focal segmental glomerulosclerosis recurrence. Pediatr. Transplant. 16, E286\u2013E290 (2012).","journal-title":"Pediatr. Transplant."},{"key":"BFnrneph201554_CR21","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1034\/j.1399-3046.2001.00051.x","volume":"5","author":"P Cochat","year":"2001","unstructured":"Cochat, P. Is there a need for a multicenter study to determine the optimal approach to recurrent nephrotic syndrome following renal transplantation? Pediatr. Transplant. 5, 394\u2013397 (2001).","journal-title":"Pediatr. Transplant."},{"key":"BFnrneph201554_CR22","first-page":"1685","volume":"23","author":"S Fargue","year":"2008","unstructured":"Fargue, S. et al. Prevention and treatment of recurrence of steroid-resistant nephrotic syndrome after kidney transplantation in children. Pediatr. Nephrol. 23, 1685 (2008).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201554_CR23","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/ki.2009.377","volume":"77","author":"BL Kasiske","year":"2010","unstructured":"Kasiske, B. L. et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int. 77, 299\u2013311 (2010).","journal-title":"Kidney Int."},{"key":"BFnrneph201554_CR24","doi-asserted-by":"crossref","unstructured":"Hodson, E. M., Willis, N. S. & Craig, J. C. Interventions for idiopathic steroid-resistant nephrotic syndrome in children. Cochrane Database of Systematic Reviews, Issue 11. Art. No.: CD003594 (2010).","DOI":"10.1002\/14651858.CD003594.pub4"},{"key":"BFnrneph201554_CR25","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/j.1399-3046.2009.01261.x","volume":"14","author":"M Vinai","year":"2010","unstructured":"Vinai, M., Waber, P. & Seikaly, M. G. Recurrence of focal segmental glomerulosclerosis in renal allograft: an in-depth review. Pediatr. Transplant. 14, 314\u2013325 (2010).","journal-title":"Pediatr. Transplant."},{"key":"BFnrneph201554_CR26","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1097\/TP.0b013e31819f12be","volume":"87","author":"LJ Hickson","year":"2009","unstructured":"Hickson, L. J. et al. Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence. Transplantation 87, 1232\u20131239 (2009).","journal-title":"Transplantation"},{"key":"BFnrneph201554_CR27","doi-asserted-by":"publisher","first-page":"E121","DOI":"10.1111\/j.1399-3046.2010.01440.x","volume":"15","author":"R Grenda","year":"2011","unstructured":"Grenda, R., Jarmuzek, W., Piatosa, B. & Rubik, J. Long-term effect of rituximab in maintaining remission of recurrent and plasmapheresis-dependent nephrotic syndrome post-renal transplantation\u2014case report. Pediatr. Transplant. 15, E121\u2013E125 (2011).","journal-title":"Pediatr. Transplant."},{"key":"BFnrneph201554_CR28","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1111\/j.1432-2277.2007.00562.x","volume":"20","author":"TN Meyer","year":"2007","unstructured":"Meyer, T. N., Thaiss, F. & Stahl, R. A. Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis. Transpl. Int. 20, 1066\u20131071 (2007).","journal-title":"Transpl. Int."},{"key":"BFnrneph201554_CR29","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00467-012-2314-6","volume":"28","author":"J Kumar","year":"2013","unstructured":"Kumar, J. et al. Rituximab in post-transplant pediatric recurrent focal segmental glomerulosclerosis. Pediatr. Nephrol. 28, 333\u2013338 (2013).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201554_CR30","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1399-3046.2008.00967.x","volume":"13","author":"US Bayrakci","year":"2009","unstructured":"Bayrakci, U. S., Baskin, E., Sakalli, H., Karakayali, H. & Haberal, M. Rituximab for post-transplant recurrences of FSGS. Pediatr. Transplant. 13, 240\u2013243 (2009).","journal-title":"Pediatr. Transplant."},{"key":"BFnrneph201554_CR31","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.1016\/j.transproceed.2011.10.051","volume":"43","author":"ZA Stewart","year":"2011","unstructured":"Stewart, Z. A., Shetty, R., Nair, R., Reed, A. I. & Brophy, P. D. Case report: successful treatment of recurrent focal segmental glomerulosclerosis with a novel rituximab regimen. Transplant. Proc. 43, 3994\u20133996 (2011).","journal-title":"Transplant. Proc."},{"key":"BFnrneph201554_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/BF00861567","volume":"7","author":"P Cochat","year":"1993","unstructured":"Cochat, P. et al. Recurrent nephrotic syndrome after transplantation: early treatment with plasmaphaeresis and cyclophosphamide. Pediatr. Nephrol. 7, 50\u201354 (1993).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201554_CR33","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s00467-005-2053-z","volume":"20","author":"S Nathanson","year":"2005","unstructured":"Nathanson, S. et al. Recurrence of nephrotic syndrome after renal transplantation: influence of increased immunosuppression. Pediatr. Nephrol. 20, 1801\u20131804 (2005).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201554_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/petr.12185","volume":"18","author":"C Straatmann","year":"2014","unstructured":"Straatmann, C. et al. Success with plasmapheresis treatment for recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients. Pediatr. Transplant. 18, 29\u201334 (2014).","journal-title":"Pediatr. Transplant."},{"key":"BFnrneph201554_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1056\/NEJM199401063300102","volume":"330","author":"J Dantal","year":"1994","unstructured":"Dantal, J. et al. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N. Engl. J. Med. 330, 7\u201314 (1994).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201554_CR36","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1016\/j.transproceed.2007.09.045","volume":"39","author":"F Fencl","year":"2007","unstructured":"Fencl, F. et al. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: case reports. Transplant. Proc. 39, 3488\u20133490 (2007).","journal-title":"Transplant. Proc."},{"key":"BFnrneph201554_CR37","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1093\/ndt\/gft453","volume":"29","author":"S Beaudreuil","year":"2014","unstructured":"Beaudreuil, S. et al. Protein A immunoadsorption cannot significantly remove the soluble receptor of urokinase from sera of patients with recurrent focal segmental glomerulosclerosis. Nephrol. Dial. Transplant. 29, 458\u2013463 (2014).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201554_CR38","unstructured":"Kwon, T., Nattes, E. & Deschenes, G. Efficacy of immunoadsorption in pediatric nephrotic syndrome. Presented at the 2014 European Society for Pediatric Nephrology meeting, Porto, Portugal."},{"key":"BFnrneph201554_CR39","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa1304572","volume":"369","author":"CC Yu","year":"2013","unstructured":"Yu, C. C. et al. Abatacept in B7-1-positive proteinuric kidney disease. N. Engl. J. Med. 369, 2416\u20132423 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201554_CR40","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1056\/NEJMc1308488","volume":"370","author":"B Basu","year":"2014","unstructured":"Basu, B. Ofatumumab for rituximab-resistant nephrotic syndrome. N. Engl. J. Med. 370, 1268\u20131270 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201554_CR41","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1007\/s00467-013-2539-z","volume":"28","author":"K Sgambat","year":"2013","unstructured":"Sgambat, K., Banks, M. & Moudgil, A. Effect of galactose on glomerular permeability and proteinuria in steroid-resistant nephrotic syndrome. Pediatr. Nephrol. 28, 2131\u20132135 (2013).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201554_CR42","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s004670050038","volume":"14","author":"R Raafat","year":"2000","unstructured":"Raafat, R., Travis, L., Kalia, A. & Diven, S. Role of transplant induction. Pediatr. Nephrol. 14, 189\u2013194 (2000).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201554_CR43","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/sj.ki.5000084","volume":"69","author":"MA Little","year":"2006","unstructured":"Little, M. A., Dupont, P., Campbell, E., Dorman, A. & Walshe, J. J. Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk. Kidney Int. 69, 504\u2013511 (2006).","journal-title":"Kidney Int."},{"key":"BFnrneph201554_CR44","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/ki.2013.377","volume":"84","author":"MC Pickering","year":"2013","unstructured":"Pickering, M. C. et al. C3 glomerulopathy: consensus report. Kidney Int. 84, 1079\u20131089 (2013).","journal-title":"Kidney Int."},{"key":"BFnrneph201554_CR45","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/ki.2011.399","volume":"81","author":"S Sethi","year":"2012","unstructured":"Sethi, S., Nester, C. M. & Smith, R. J. H. Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion. Kidney Int. 81, 434\u2013441 (2012).","journal-title":"Kidney Int."},{"key":"BFnrneph201554_CR46","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1681\/ASN.2013070715","volume":"25","author":"L Zand","year":"2014","unstructured":"Zand, L. et al. Clinical findings, pathology, and outcomes of C3GN after kidney transplantation. J. Am. Soc. Nephrol. 25, 1110\u20131117 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201554_CR47","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/ki.2010.1","volume":"77","author":"EC Lorenz","year":"2010","unstructured":"Lorenz, E. C. et al. Recurrent membranoproliferative glomerulonephritis after kidney transplantation. Kidney Int. 77, 721\u2013728 (2010).","journal-title":"Kidney Int."},{"key":"BFnrneph201554_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.transproceed.2012.12.021","volume":"45","author":"S Marinaki","year":"2013","unstructured":"Marinaki, S., Lionaki, S. & Boletis, J. N. Glomerular disease recurrence in the renal allograft: a hurdle but not a barrier for successful kidney transplantation. Transplant. Proc. 45, 3\u20139 (2013).","journal-title":"Transplant. Proc."},{"key":"BFnrneph201554_CR49","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1111\/j.1600-6143.2011.03923.x","volume":"12","author":"JA McCaughan","year":"2012","unstructured":"McCaughan, J. A., O'Rourke, D. M. & Courtney, A. E. Recurrent dense deposit disease after renal transplantation: an emerging role for complementary therapies. Am. J. Transplant. 12, 1046\u20131051 (2012).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201554_CR50","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1056\/NEJMc1106619","volume":"366","author":"S Radhakrishnan","year":"2012","unstructured":"Radhakrishnan, S. et al. Eculizumab and refractory membranoproliferative glomerulonephritis. N. Engl. J. Med. 366, 1165\u20131166 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201554_CR51","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1007\/s00467-013-2503-y","volume":"28","author":"S Gurkan","year":"2013","unstructured":"Gurkan, S. et al. Eculizumab and recurrent C3 glomerulonephritis. Pediatr. Nephrol. 28, 1975\u20131981 (2013).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201554_CR52","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.2215\/CJN.10181110","volume":"6","author":"C Nester","year":"2011","unstructured":"Nester, C. et al. Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome. Clin. J. Am. Soc. Nephrol. 6, 1488\u20131494 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201554_CR53","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1093\/ndt\/gfq223","volume":"25","author":"G Moroni","year":"2010","unstructured":"Moroni, G. et al. Long-term outcome of renal transplantation in patients with idiopathic membranous glomerulonephritis (MN). Nephrol. Dial. Transplant. 25, 3408\u20133415 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201554_CR54","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"LH Beck Jr","year":"2009","unstructured":"Beck, L. H. Jr et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N. Engl. J. Med. 361, 11\u201321 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201554_CR55","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1111\/j.1600-6143.2011.03643.x","volume":"11","author":"H Debiec","year":"2011","unstructured":"Debiec, H. et al. Autoantibodies specific for the phospholipase A2 receptor in recurrent and de novo membranous nephropathy. Am. J. Transplant. 11, 2144\u20132152 (2011).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201554_CR56","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1111\/j.1600-6143.2009.02851.x","volume":"9","author":"ZM El-Zoghby","year":"2009","unstructured":"El-Zoghby, Z. M. et al. Recurrent idiopathic membranous nephropathy: early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies. Am. J. Transplant. 9, 2800\u20132807 (2009).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201554_CR57","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/j.1600-6143.2011.03903.x","volume":"12","author":"EF Rodriguez","year":"2012","unstructured":"Rodriguez, E. F. et al. The pathology and clinical features of early recurrent membranous glomerulonephritis. Am. J. Transplant. 12, 1029\u20131038 (2012).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201554_CR58","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/ndt\/14.1.239","volume":"14","author":"PA Andrews","year":"1999","unstructured":"Andrews, P. A. Lipoprotein glomerulopathy: a new cause of nephrotic syndrome after renal transplantation. Implications for renal transplantation. Nephrol. Dial. Transplant. 14, 239\u2013240 (1999).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201554_CR59","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1399-3046.2008.00910.x","volume":"12","author":"C Loirat","year":"2008","unstructured":"Loirat, C. & Fremeaux-Bacchi, V. Hemolytic uremic syndrome recurrence after renal transplantation. Pediatr. Transplant. 12, 619\u2013629 (2008).","journal-title":"Pediatr. Transplant."},{"key":"BFnrneph201554_CR60","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1681\/ASN.2006080811","volume":"18","author":"AL Sellier-Leclerc","year":"2007","unstructured":"Sellier-Leclerc, A. L. et al. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J. Am. Soc. Nephrol. 18, 2392\u20132400 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201554_CR61","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1093\/ndt\/gfn063","volume":"23","author":"T Kwon","year":"2008","unstructured":"Kwon, T. et al. Successful pre-transplant management of a patient with anti-factor H autoantibodies-associated haemolytic uraemic syndrome. Nephrol. Dial. Transplant. 23, 2088\u20132090 (2008).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201554_CR62","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00467-008-0863-5","volume":"24","author":"C Loirat","year":"2009","unstructured":"Loirat, C., Girma, J. P., Desconclois, C., Coppo, P. & Veyradier, A. Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children. Pediatr. Nephrol. 24, 19\u201329 (2009).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201554_CR63","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1055\/s-2006-939767","volume":"32","author":"LB Zimmerhackl","year":"2006","unstructured":"Zimmerhackl, L. B. et al. Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome. Semin. Thromb. Hemost. 32, 113\u2013120 (2006).","journal-title":"Semin. Thromb. Hemost."},{"key":"BFnrneph201554_CR64","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.trre.2013.07.003","volume":"27","author":"J Zuber","year":"2013","unstructured":"Zuber, J. et al. Targeted strategies in the prevention and management of atypical HUS recurrence after kidney transplantation. Transplant. Rev. (Orlando) 27, 117\u2013125 (2013).","journal-title":"Transplant. Rev. (Orlando)"},{"key":"BFnrneph201554_CR65","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/ajt.12077","volume":"13","author":"M Le Quintrec","year":"2013","unstructured":"Le Quintrec, M. et al. Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome. Am. J. Transplant. 13, 663\u2013675 (2013).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201554_CR66","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/ng.2590","volume":"45","author":"M Lemaire","year":"2013","unstructured":"Lemaire, M. et al. Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome. Nat. Genet. 45, 531\u2013536 (2013).","journal-title":"Nat. Genet."},{"key":"BFnrneph201554_CR67","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1681\/ASN.2012090884","volume":"24","author":"E Bresin","year":"2013","unstructured":"Bresin, E. et al. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype. J. Am. Soc. Nephrol. 24, 475\u2013486 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201554_CR68","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s00467-013-2450-7","volume":"28","author":"WL Pabst","year":"2013","unstructured":"Pabst, W. L. et al. Successful long-term outcome after renal transplantation in a patient with atypical haemolytic uremic syndrome with combined membrane cofactor protein CD46 and complement factor I mutations. Pediatr. Nephrol. 28, 1141\u20131144 (2013).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201554_CR69","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1007\/s00467-014-2933-1","volume":"29","author":"K Michaux","year":"2014","unstructured":"Michaux, K. et al. Eculizumab in neonatal hemolytic uremic syndrome with homozygous factor H deficiency. Pediatr. Nephrol. 29, 2415\u20132419 (2014).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201554_CR70","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1093\/ndt\/gfp377","volume":"24","author":"P Hirt-Minkowski","year":"2009","unstructured":"Hirt-Minkowski, P. et al. Haemolytic uraemic syndrome caused by factor H mutation: is single kidney transplantation under intensive plasmatherapy an option? Nephrol. Dial. Transplant. 24, 3548\u20133551 (2009).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201554_CR71","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1111\/j.1600-6143.2012.04252.x","volume":"12","author":"J Zuber","year":"2012","unstructured":"Zuber, J. et al. Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation. Am. J. Transplant. 12, 3337\u20133354 (2012).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201554_CR72","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s00467-011-1879-9","volume":"26","author":"M Weitz","year":"2011","unstructured":"Weitz, M., Amon, O., Bassler, D., Koenigsrainer, A. & Nadalin, S. Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome. Pediatr. Nephrol. 26, 1325\u20131329 (2011).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201554_CR73","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00467-010-1708-6","volume":"26","author":"SI Al-Akash","year":"2011","unstructured":"Al-Akash, S. I., Almond, P. S., Savell, V. H. Jr, Gharaybeh, S. I. & Hogue, C. Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation. Pediatr. Nephrol. 26, 613\u2013619 (2011).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201554_CR74","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.1016\/j.transproceed.2010.09.125","volume":"42","author":"V Chatelet","year":"2010","unstructured":"Chatelet, V. et al. Eculizumab: safety and efficacy after 17 months of treatment in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome: case report. Transplant. Proc. 42, 4353\u20134355 (2010).","journal-title":"Transplant. Proc."},{"key":"BFnrneph201554_CR75","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","volume":"368","author":"CM Legendre","year":"2013","unstructured":"Legendre, C. M. et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N. Engl. J. Med. 368, 2169\u20132181 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201554_CR76","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00467-013-2591-8","volume":"29","author":"E Roman-Ortiz","year":"2014","unstructured":"Roman-Ortiz, E. et al. Eculizumab long-term therapy for pediatric renal transplant in aHUS with CFH\/CFHR1 hybrid gene. Pediatr. Nephrol. 29, 149\u2013153 (2014).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201554_CR77","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/MOP.0b013e32835e7888","volume":"25","author":"C Loirat","year":"2013","unstructured":"Loirat, C., Coppo, P. & Veyradier, A. Thrombotic thrombocytopenic purpura in children. Curr. Opin. Pediatr. 25, 216\u2013224 (2013).","journal-title":"Curr. Opin. Pediatr."},{"key":"BFnrneph201554_CR78","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00467-014-2948-7","volume":"30","author":"P Khandelwal","year":"2015","unstructured":"Khandelwal, P. et al. Effect of plasma exchange and immunosuppressive medications on antibody titers and outcome in anti-complement factor H antibody-associated hemolytic uremic syndrome. Pediatr. Nephrol. 30, 451\u2013457 (2015).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201554_CR79","doi-asserted-by":"publisher","first-page":"E134","DOI":"10.1111\/petr.12273","volume":"18","author":"P Khandelwal","year":"2014","unstructured":"Khandelwal, P. et al. Outcomes of renal transplant in patients with anti-complement factor H antibody-associated hemolytic uremic syndrome. Pediatr. Transplant. 18, E134\u2013E139 (2014).","journal-title":"Pediatr. Transplant."},{"key":"BFnrneph201554_CR80","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1097\/TP.0b013e3181a991ca","volume":"87","author":"K Midtvedt","year":"2009","unstructured":"Midtvedt, K., Bitter, J. & Dorje, C. Belatacept as immunosuppression in patient with recurrence of HUS after renal transplantation. Transplantation 87, 1901\u20131903 (2009).","journal-title":"Transplantation"},{"key":"BFnrneph201554_CR81","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1182\/blood-2014-02-558296","volume":"124","author":"M Noris","year":"2014","unstructured":"Noris, M. et al. Dynamics of complement activation in aHUS and how to monitor eculizumab therapy. Blood 124, 1715\u20131726 (2014).","journal-title":"Blood"},{"key":"BFnrneph201554_CR82","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1056\/NEJMra1301564","volume":"369","author":"P Cochat","year":"2013","unstructured":"Cochat, P. & Rumsby, G. Primary hyperoxaluria. N. Engl. J. Med. 369, 649\u2013658 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201554_CR83","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1093\/ndt\/gfs078","volume":"27","author":"P Cochat","year":"2012","unstructured":"Cochat, P. et al. Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment. Nephrol. Dial. Transplant. 27, 1729\u20131736 (2012).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201554_CR84","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/petr.12243","volume":"18","author":"G Filler","year":"2014","unstructured":"Filler, G. & Hoppe, B. Combined liver-kidney transplantation for hyperoxaluria type II? Pediatr. Transplant. 18, 237\u2013239 (2014).","journal-title":"Pediatr. Transplant."},{"key":"BFnrneph201554_CR85","doi-asserted-by":"publisher","first-page":"864580","DOI":"10.4061\/2011\/864580","volume":"2011","author":"J Harambat","year":"2011","unstructured":"Harambat, J., Fargue, S., Bacchetta, J., Acquaviva, C. & Cochat, P. Primary hyperoxaluria. Int. J. Nephrol. 2011, 864580 (2011).","journal-title":"Int. J. Nephrol."},{"key":"BFnrneph201554_CR86","doi-asserted-by":"publisher","first-page":"E69","DOI":"10.1111\/petr.12240","volume":"18","author":"G Naderi","year":"2014","unstructured":"Naderi, G., Latif, A., Tabassomi, F. & Esfahani, S. T. Failure of isolated kidney transplantation in a pediatric patient with primary hyperoxaluria type 2. Pediatr. Transplant. 18, E69\u2013E73 (2014).","journal-title":"Pediatr. Transplant."},{"key":"BFnrneph201554_CR87","doi-asserted-by":"publisher","first-page":"458","DOI":"10.2215\/CJN.07430711","volume":"7","author":"J Harambat","year":"2012","unstructured":"Harambat, J. et al. Characteristics and outcomes of children with primary oxalosis requiring renal replacement therapy. Clin. J. Am. Soc. Nephrol. 7, 458\u2013465 (2012).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201554_CR88","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1097\/TP.0b013e3181a27939","volume":"87","author":"F Brinkert","year":"2009","unstructured":"Brinkert, F. et al. Transplantation procedures in children with primary hyperoxaluria type 1: outcome and longitudinal growth. Transplantation 87, 1415\u20131421 (2009).","journal-title":"Transplantation"},{"key":"BFnrneph201554_CR89","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/ndt\/gfq353","volume":"26","author":"MT Perera","year":"2011","unstructured":"Perera, M. T. et al. Pre-emptive liver transplantation for primary hyperoxaluria (PHI) arrests long-term renal function deterioration. Nephrol. Dial. Transplant. 26, 354\u2013359 (2011).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201554_CR90","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1159\/000086359","volume":"25","author":"NV Jamieson","year":"2005","unstructured":"Jamieson, N. V. & the European PH1 Transplantation Study Group. A 20-year experience of combined liver\/kidney transplantation for primary hyperoxaluria (PH1): the European PH1 transplant registry experience 1984\u20132004. Am. J. Nephrol. 25, 282\u2013289 (2005).","journal-title":"Am. J. Nephrol."},{"key":"BFnrneph201554_CR91","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/00007890-200209150-00020","volume":"74","author":"DM Cibrik","year":"2002","unstructured":"Cibrik, D. M., Kaplan, B., Arndorfer, J. A. & Meier-Kriesche, H. U. Renal allograft survival in patients with oxalosis. Transplantation 74, 707\u2013710 (2002).","journal-title":"Transplantation"},{"key":"BFnrneph201554_CR92","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1097\/01.TP.0000084203.76110.AC","volume":"76","author":"MT Millan","year":"2003","unstructured":"Millan, M. T. et al. One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single-center experience. Transplantation 76, 1458\u20131463 (2003).","journal-title":"Transplantation"},{"key":"BFnrneph201554_CR93","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/ndt\/16.2.348","volume":"16","author":"SR Ellis","year":"2001","unstructured":"Ellis, S. R., Hulton, S. A., McKiernan, P. J., de Ville de Goyet, J. & Kelly, D. A. Combined liver-kidney transplantation for primary hyperoxaluria type 1 in young children. Nephrol. Dial. Transplant. 16, 348\u2013354 (2001).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201554_CR94","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1111\/j.1600-6143.2010.03271.x","volume":"10","author":"EJ Bergstralh","year":"2010","unstructured":"Bergstralh, E. J. et al. Transplantation outcomes in primary hyperoxaluria. Am. J. Transplant. 10, 2493\u20132501 (2010).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201554_CR95","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/j.1399-3046.2008.01049.x","volume":"13","author":"I Malla","year":"2009","unstructured":"Malla, I. et al. Two-step transplantation for primary hyperoxaluria: cadaveric liver followed by living donor related kidney transplantation. Pediatr. Transplant. 13, 782\u2013784 (2009).","journal-title":"Pediatr. Transplant."},{"key":"BFnrneph201554_CR96","unstructured":"Lai, C. et al. Inhibition of glycolate oxidase (HAO1) with dicer-substrate siRNAs as a substrate reduction therapy for primary hyperoxaluria Type I [online] , (2014)."},{"key":"BFnrneph201554_CR97","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.2215\/CJN.02320312","volume":"7","author":"G Bollee","year":"2012","unstructured":"Bollee, G. et al. Adenine phosphoribosyltransferase deficiency. Clin. J. Am. Soc. Nephrol. 7, 1521\u20131527 (2012).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201554_CR98","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00467-011-2037-0","volume":"27","author":"J Harambat","year":"2012","unstructured":"Harambat, J., Bollee, G., Daudon, M., Ceballos-Picot, I. & Bensman, A. Adenine phosphoribosyltransferase deficiency in children. Pediatr. Nephrol. 27, 571\u2013579 (2012).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201554_CR99","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S0272-6386(12)80168-5","volume":"24","author":"ER Gagne","year":"1994","unstructured":"Gagne, E. R., Deland, E., Daudon, M., Noel, L. H. & Nawar, T. Chronic renal failure secondary to 2, 8-dihydroxyadenine deposition: the first report of recurrence in a kidney transplant. Am. J. Kidney Dis. 24, 104\u2013107 (1994).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201554_CR100","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/ndt\/gfg562","volume":"19","author":"MJ Cassidy","year":"2004","unstructured":"Cassidy, M. J., McCulloch, T., Fairbanks, L. D. & Simmonds, H. A. Diagnosis of adenine phosphoribosyltransferase deficiency as the underlying cause of renal failure in a renal transplant recipient. Nephrol. Dial. Transplant. 19, 736\u2013738 (2004).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201554_CR101","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1681\/ASN.2013090960","volume":"25","author":"K Kaartinen","year":"2014","unstructured":"Kaartinen, K. et al. Adenine phosphoribosyltransferase deficiency as a rare cause of renal allograft dysfunction. J. Am. Soc. Nephrol. 25, 671\u2013674 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201554_CR102","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1053\/j.ajkd.2009.12.028","volume":"56","author":"P Stratta","year":"2010","unstructured":"Stratta, P. et al. Decreased kidney function and crystal deposition in the tubules after kidney transplant. Am. J. Kidney Dis. 56, 585\u2013590 (2010).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201554_CR103","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1093\/ndt\/gfp711","volume":"25","author":"SH Nasr","year":"2010","unstructured":"Nasr, S. H. et al. Crystalline nephropathy due to 2, 8-dihydroxyadeninuria: an under-recognized cause of irreversible renal failure. Nephrol. Dial. Transplant. 25, 1909\u20131915 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201554_CR104","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1111\/ajt.12926","volume":"14","author":"M Zaidan","year":"2014","unstructured":"Zaidan, M. et al. Recurrent 2, 8-dihydroxyadenine nephropathy: a rare but preventable cause of renal allograft failure. Am. J. Transplant. 14, 2623\u20132632 (2014).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201554_CR105","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1681\/ASN.2009080808","volume":"21","author":"G Bollee","year":"2010","unstructured":"Bollee, G. et al. Phenotype and genotype characterization of adenine phosphoribosyltransferase deficiency. J. Am. Soc. Nephrol. 21, 679\u2013688 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201554_CR106","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s00467-008-1096-3","volume":"25","author":"RJ Hogg","year":"2010","unstructured":"Hogg, R. J. Idiopathic immunoglobulin A nephropathy in children and adolescents. Pediatr. Nephrol. 25, 823\u2013829 (2010).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201554_CR107","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1093\/ndt\/gfr664","volume":"27","author":"F Ortiz","year":"2012","unstructured":"Ortiz, F. et al. IgA nephropathy recurs early in the graft when assessed by protocol biopsy. Nephrol. Dial. Transplant. 27, 2553\u20132558 (2012).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201554_CR108","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1053\/j.ajkd.2006.02.178","volume":"47","author":"R Coppo","year":"2006","unstructured":"Coppo, R. et al. Predictors of outcome in Henoch-Schonlein nephritis in children and adults. Am. J. Kidney Dis. 47, 993\u20131003 (2006).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201554_CR109","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1136\/adc.2005.074641","volume":"90","author":"H Narchi","year":"2005","unstructured":"Narchi, H. Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review. Arch. Dis. Child. 90, 916\u2013920 (2005).","journal-title":"Arch. Dis. Child."},{"key":"BFnrneph201554_CR110","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1399-0012.2007.00730.x","volume":"21","author":"R Coppo","year":"2007","unstructured":"Coppo, R. et al. Serological and genetic factors in early recurrence of IgA nephropathy after renal transplantation. Clin. Transplant. 21, 728\u2013737 (2007).","journal-title":"Clin. Transplant."},{"key":"BFnrneph201554_CR111","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.2215\/CJN.00520111","volume":"6","author":"N Kanaan","year":"2011","unstructured":"Kanaan, N. et al. Recurrence and graft loss after kidney transplantation for henoch-schonlein purpura nephritis: a multicenter analysis. Clin. J. Am. Soc. Nephrol. 6, 1768\u20131772 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201554_CR112","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1093\/ndt\/gfn209","volume":"23","author":"G Moroni","year":"2008","unstructured":"Moroni, G. et al. Renal transplantation in adults with Henoch-Schonlein purpura: long-term outcome. Nephrol. Dial. Transplant. 23, 3010\u20133016 (2008).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201554_CR113","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1177\/0961203311430220","volume":"21","author":"CS Oliveira","year":"2012","unstructured":"Oliveira, C. S. et al. Renal transplantation in lupus nephritis: a Brazilian cohort. Lupus 21, 570\u2013574 (2012).","journal-title":"Lupus"},{"key":"BFnrneph201554_CR114","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1053\/j.ajkd.2005.01.038","volume":"45","author":"G Moroni","year":"2005","unstructured":"Moroni, G. et al. The long-term prognosis of renal transplantation in patients with lupus nephritis. Am. J. Kidney Dis 45, 903\u2013911 (2005).","journal-title":"Am. J. Kidney Dis"},{"key":"BFnrneph201554_CR115","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s10067-011-1931-y","volume":"31","author":"TM Yu","year":"2012","unstructured":"Yu, T. M. et al. Impact of recurrent lupus nephritis on lupus kidney transplantation: a 20-year single center experience. Clin. Rheumatol. 31, 705\u2013710 (2012).","journal-title":"Clin. Rheumatol."},{"key":"BFnrneph201554_CR116","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1002\/art.24776","volume":"60","author":"PI Burgos","year":"2009","unstructured":"Burgos, P. I. et al. Risk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation: date from a single US institution. Arthritis Rheum. 60, 2757\u20132766 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrneph201554_CR117","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1136\/ard.2009.122796","volume":"69","author":"GE Norby","year":"2010","unstructured":"Norby, G. E. et al. Recurrent lupus nephritis after kidney transplantation: a surveillance biopsy study. Ann. Rheum. Dis. 69, 1484\u20131487 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrneph201554_CR118","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/S0272-6386(99)70009-0","volume":"34","author":"JH Stone","year":"1999","unstructured":"Stone, J. H., Amend, W. J. & Criswell, L. A. Antiphospholipid antibody syndrome in renal transplantation: occurrence of clinical events in 96 consecutive patients with systemic lupus erythematosus. Am. J. Kidney Dis. 34, 1040\u20131047 (1999).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201554_CR119","first-page":"301","volume":"32","author":"C Gonzalez-Pulido","year":"2014","unstructured":"Gonzalez-Pulido, C., Croca, S., Abrol, E. & Isenberg, D. A. Long-term activity index after renal failure in a cohort of 32 patients with lupus nephritis. Clin. Exp. Rheumatol. 32, 301\u2013307 (2014).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrneph201554_CR120","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1177\/0961203308089439","volume":"17","author":"TM Yu","year":"2008","unstructured":"Yu, T. M. et al. Renal outcome and evolution of disease activity in Chinese lupus patients after renal transplantation. Lupus 17, 687\u2013694 (2008).","journal-title":"Lupus"},{"key":"BFnrneph201554_CR121","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1097\/00007890-200109270-00016","volume":"72","author":"GS Friedman","year":"2001","unstructured":"Friedman, G. S. et al. Hypercoagulable states in renal transplant candidates: impact of anticoagulation upon incidence of renal allograft thrombosis. Transplantation 72, 1073\u20131078 (2001).","journal-title":"Transplantation"},{"key":"BFnrneph201554_CR122","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1034\/j.1600-6143.2002.20910.x","volume":"2","author":"PE Morrissey","year":"2002","unstructured":"Morrissey, P. E. et al. Management of thrombophilia in renal transplant patients. Am. J. Transplant. 2, 872\u2013876 (2002).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201554_CR123","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/nep.12217","volume":"19","author":"TD Barbour","year":"2014","unstructured":"Barbour, T. D. et al. Antiphospholipid syndrome in renal transplantation. Nephrology (Carlton) 19, 177\u2013185 (2014).","journal-title":"Nephrology (Carlton)"},{"key":"BFnrneph201554_CR124","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/j.1432-2277.2007.00555.x","volume":"20","author":"C Falkeis","year":"2007","unstructured":"Falkeis, C. et al. Kidney transplantation in patients suffering from hereditary complete complement C4 deficiency. Transpl. Int. 20, 1044\u20131049 (2007).","journal-title":"Transpl. Int."},{"key":"BFnrneph201554_CR125","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1093\/ndt\/gfp347","volume":"24","author":"MA Little","year":"2009","unstructured":"Little, M. A. et al. Renal transplantation in systemic vasculitis: when is it safe? Nephrol. Dial. Transplant. 24, 3219\u20133125 (2009).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201554_CR126","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S0272-6386(03)00025-8","volume":"41","author":"AD Booth","year":"2003","unstructured":"Booth, A. D. et al. Outcome of ANCA-associated renal vasculitis: a 5year retrospective study. Am. J. Kidney Dis. 41, 776\u2013784 (2003).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201554_CR127","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/ctr.12084","volume":"27","author":"H Marco","year":"2013","unstructured":"Marco, H. et al. Long-term outcome of antineutrophil cytoplasmic antibody-associated small vessel vasculitis after renal transplantation. Clin. Transplant. 27, 338\u2013347 (2013).","journal-title":"Clin. Transplant."},{"key":"BFnrneph201554_CR128","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1093\/ndt\/gfg087","volume":"18","author":"A Elmedhem","year":"2003","unstructured":"Elmedhem, A., Adu, D. & Savage, C. O. Relapse rate and outcome of ANCA-associated small vessel vasculitis after transplantation. Nephrol. Dial. Transplant. 18, 1001\u20131004 (2003).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201554_CR129","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/tri.12203","volume":"26","author":"C Murakami","year":"2013","unstructured":"Murakami, C., Manoharan, P., Carter-Monroe, N. & Geetha, D. Rituximab for remission induction in recurrent ANCA-associated glomerulonephritis postkidney transplant. Transpl. Int. 26, 1225\u20131231 (2013).","journal-title":"Transpl. Int."},{"key":"BFnrneph201554_CR130","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1111\/j.1600-6143.2007.01985.x","volume":"7","author":"D Geetha","year":"2007","unstructured":"Geetha, D., Seo, P., Specks, U. & Fervenza, F. C. Successful induction of remission with rituximab for relapse of ANCA-associated vasculitis post-kidney transplant: report of two cases. Am. J. Transplant. 7, 2821\u20132825 (2007).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201554_CR131","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.2215\/CJN.02000311","volume":"6","author":"KJ Van Stralen","year":"2011","unstructured":"Van Stralen, K. J. et al. Improvement in the renal prognosis in nephropathic cystinosis. Clin. J. Am. Soc. Nephrol. 6, 2485\u20132491 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201554_CR132","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1097\/00007890-200006150-00020","volume":"69","author":"A Ojo","year":"2000","unstructured":"Ojo, A. et al. Excellent outcome of renal transplantation in patients with Fabry's disease. Transplantation 69, 2337\u20132339 (2000).","journal-title":"Transplantation"},{"key":"BFnrneph201554_CR133","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1525-139X.2010.00708.x","volume":"23","author":"FL Luan","year":"2010","unstructured":"Luan, F. L. & Samaniego, M. Transplantation in diabetic kidney failure patients: modalities, outcomes, and clinical management. Semin. Dial. 23, 198\u2013205 (2010).","journal-title":"Semin. Dial."},{"key":"BFnrneph201554_CR134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.6002\/ect.2011.0098","volume":"10","author":"J Nath","year":"2012","unstructured":"Nath, J. et al. Sickle cell and renal transplant: a national survey and literature review. Exp. Clin. Transplant. 10, 1\u20137 (2012).","journal-title":"Exp. Clin. Transplant."},{"key":"BFnrneph201554_CR135","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1111\/j.1399-3046.2009.01173.x","volume":"14","author":"F Vargas","year":"2010","unstructured":"Vargas, F., Gedalia, A., Craver, R. D. & Matti Vehaskari, V. Recurrence of granulomatous interstitial nephritis in transplanted kidney. Pediatr. Transplant. 14, e54\u2013e57 (2010).","journal-title":"Pediatr. Transplant."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2015.54.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2015.54","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2015.54.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T17:05:10Z","timestamp":1717866310000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2015.54"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,28]]},"references-count":135,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["BFnrneph201554"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2015.54","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,28]]},"assertion":[{"value":"28 April 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}